Long-term investment in the stock market always proves profitable, especially when the investment is made in good companies. Sudarshan Pharma Industries is a great example of this. The company has given excellent returns to investors in recent years.
Investors’ stake increased after share distribution
- November 2024: Sudarshan Pharma split its shares.
- Face value: Earlier it was Rs 10, which reduced to Rs 1 per share.
- On Friday, January 10, 2025, the company’s shares fell by 2%.
Journey from IPO till now
- IPO launch:
The company’s IPO was launched on 9 March 2023.- Lot Size: 1600 shares.
- Minimum investment: Rs 1,16,800.
- After share split:
Investors now hold a total of 16,000 shares. - Current share price (10 January 2025):
Rs 48.80 per share on BSE. - Return:
The investment of Rs 1.16 lakh has increased to Rs 7.80 lakh in about 2 years.- That means investors have got 7 times return.
Company performance and market cap
- 52 Week High: Rs 53.50.
- 52 Week Low: Rs 5.82.
- Market Cap: Rs 1174.42 crore.
Sudarshan Pharma business
Sudarshan Pharma provides various services to the pharma and chemical industry.
- Export Market:
The company exports its products to countries like UK, Australia, Uzbekistan, Syria, Oman, Taiwan. - Services:
- Contract Manufacturing.
- Outsourcing.
- Supply of generic formulations and medicines.
According to the company’s website, it is known for innovative solutions and quality products.
